100
Participants
Start Date
February 28, 2010
Primary Completion Date
June 1, 2011
Study Completion Date
July 1, 2011
Neovasculgen (Cambiogeneplasmid)
treatment
Russian National Surgery Center by Petrovsky, Moscow
Yaroslavl State Medical Academy, Yaroslavl
Ryazansky State Medical University, Ryazan
Lead Sponsor
Artgen Biotech
OTHER